CanBas Co. Ltd.

CanBas Co. Ltd.
Stock Exchange Tokyo Stock Exchange
EPS
JPY86.49
Market Cap
JPY5.99 B
Shares Outstanding
6.83 M
Public Float
5.54 M

Profile

Address
2-2-1 Otemachi
Numazu Shizuoka 410
Japan
Employees -
Website http://www.canbas.co.jp
Updated 07/08/2019
CanBas Co., Ltd. engages in pharmaceutical business. It focuses on the research and development of anti-cancer agent, drugs, and technologies which has minor impact on normal cell. Its technologies include drugs for the G2 check point and a screening system to find selective abrogates of the G2 check point.

Financials

View All
Created with Highcharts 5.0.14CanBas Co. Ltd.Net Income. Fiscal year is July-June. All values JPY Thousands.376 269376 269266 964266 964414 989414 989419 498419 498532 087532 087201420152016201720180100k200k300k400k500k600k
Created with Highcharts 5.0.14CanBas Co. Ltd.Sales/Revenue. Fiscal year is July-June. All values JPY Thousands.0060 95860 958105 243105 243109 852109 852110 000110 00020142015201620172018025k50k75k100k125k

Takumi Kawabe
President & Representative Director
Makoto Katozumi
CFO, Director & Manager-Administration